V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20191112 | 20123520 | 1.76 | 88.7 | null | 2019-09-05 | 2020-09-25 | CAPECITABINE + IRINOTECAN | 02 | null | CAPECITABINE + IRINOTECAN | 101622064 |
| 20191113 | 20123521 | 1.7 | 72 | null | 2020-02-01 | 2020-02-05 | Capecitabine (14 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 100818036 |
| 20191118 | 20123522 | 1.67 | null | Palliative (P) | 2017-02-18 | 2017-03-18 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 101306847 |
| 20191127 | 20123523 | 1.79 | 48.4 | Palliative (P) | 2016-08-28 | 2016-09-07 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101262225 |
| 20191130 | 20123524 | 1.82 | 65.8 | null | 2019-08-16 | 2019-11-24 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 101870880 |
| 20191134 | 20123525 | 1.84 | 61.2 | Palliative (P) | 2019-08-30 | 2019-09-13 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100135849 |
| 20191139 | 20123526 | 1.65 | 74.2 | Palliative (P) | 2018-11-16 | 2018-11-16 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100093466 |
| 20191144 | 20123527 | 1.69 | 72 | Neo-adjuvant (N) | 2019-12-27 | 2019-12-27 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 100526750 |
| 20191145 | 20123528 | 1.57 | 63.2 | Neo-adjuvant (N) | 2020-08-05 | 2020-08-25 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 100100491 |
| 20191149 | 20123529 | 1.74 | 53.15 | null | 2018-10-25 | 2019-06-29 | CISPLATIN + GEMCITABINE | 02 | null | CISPLATIN + GEMCITABINE | 101835058 |
| 20191150 | 20123530 | 1.76 | 78 | Palliative (P) | 2021-02-21 | 2021-02-25 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | CISPLATIN + GEMCITABINE | 100563798 |
| 20191152 | 20123531 | 1.76 | 89.15 | Palliative (P) | 2016-09-18 | 2017-09-17 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100985040 |
| 20191154 | 20123532 | 1.79 | 90.6 | Palliative (P) | 2018-11-11 | 2018-11-24 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101130219 |
| 20191159 | 20123533 | 1.67 | 69.3 | null | 2016-07-12 | 2016-07-19 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 100240867 |
| 20191160 | 20123534 | 1.7 | 50.25 | Palliative (P) | 2017-09-09 | 2017-09-09 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101186083 |
| 20191163 | 20123535 | 1.44 | 73.8 | Palliative (P) | 2017-06-30 | 2017-07-05 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101775059 |
| 20191165 | 20123536 | 1.69 | 70.5 | null | 2016-12-11 | 2017-03-02 | Capecitabine (14 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 101804864 |
| 20191169 | 20123537 | 1.74 | 68 | Palliative (P) | 2018-05-18 | 2018-09-06 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100609379 |
| 20191172 | 20123538 | 1.55 | 108.4 | Palliative (P) | 2019-12-17 | 2020-01-19 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 101821442 |
| 20191178 | 20123539 | 1.85 | 91.6 | null | 2020-02-17 | 2020-03-01 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100167053 |
| 20191179 | 20123540 | 1.55 | 86.9 | Palliative (P) | 2017-11-14 | 2017-11-14 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 100209530 |
| 20191180 | 20123541 | 1.5 | 64.1 | Palliative (P) | 2017-05-27 | 2017-06-17 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 100859585 |
| 20191182 | 20123542 | 1.74 | 41 | Palliative (P) | 2018-11-26 | 2018-12-04 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100920069 |
| 20191185 | 20123543 | 1.7 | 94.4 | null | null | 2018-04-14 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101300313 |
| 20191189 | 20123544 | 1.6 | 67 | Palliative (P) | 2020-02-21 | 2020-03-06 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101270797 |
| 20191190 | 20123545 | 1.87 | 75.2 | Palliative (P) | 2016-11-07 | 2017-09-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100114323 |
| 20191193 | 20123546 | 1.79 | 77.6 | Palliative (P) | null | 2018-06-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100082110 |
| 20191196 | 20123547 | 1.53 | 59.9 | Palliative (P) | 2018-08-27 | 2018-09-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100657892 |
| 20191197 | 20123548 | 1.61 | 54 | Palliative (P) | 2019-08-29 | 2019-08-29 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100143023 |
| 20191199 | 20123549 | 1.69 | 98 | Palliative (P) | 2018-03-19 | 2018-05-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101693381 |
| 20191201 | 20123550 | 1.73 | 56.5 | Palliative (P) | 2018-01-06 | 2018-03-29 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100813120 |
| 20191207 | 20123551 | 1.66 | 61 | Palliative (P) | null | 2019-03-11 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100755258 |
| 20191211 | 20123552 | 1.74 | 64.5 | Palliative (P) | 2016-08-29 | 2016-09-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101120255 |
| 20191215 | 20123553 | 1.76 | 55.6 | Palliative (P) | 2021-03-30 | 2021-04-03 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101493455 |
| 20191216 | 20123554 | 1.81 | 69.3 | Palliative (P) | 2018-07-05 | 2018-07-14 | Docetaxel 75mg/m2 (21 day) | 2 | N | DOCETAXEL | 101856728 |
| 20191217 | 20123555 | 1.94 | 56.9 | Adjuvant (A) | 2019-02-23 | 2019-05-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101013822 |
| 20191222 | 20123556 | 1.83 | 66 | null | 2019-10-22 | 2019-10-29 | Docetaxel | 02 | null | DOCETAXEL | 101005153 |
| 20191225 | 20123557 | 1.65 | 46.4 | null | 2020-03-01 | 2020-03-16 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100809227 |
| 20191226 | 20123558 | 1.67 | 61.8 | Palliative (P) | 2019-02-14 | 2019-02-28 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101725562 |
| 20191230 | 20123559 | 1.7 | 56 | Palliative (P) | 2019-04-06 | 2019-08-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101201422 |
| 20191232 | 20123560 | 1.62 | 74.3 | null | 2017-05-24 | 2017-06-16 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101569833 |
| 20191234 | 20123561 | 1.55 | 69.2 | Palliative (P) | 2020-01-28 | 2020-02-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101786340 |
| 20191236 | 20123562 | 1.76 | 69.3 | Palliative (P) | 2018-12-09 | 2018-12-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101565549 |
| 20191239 | 20123563 | 1.76 | null | Palliative (P) | 2017-01-31 | 2017-02-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101753522 |
| 20191240 | 20123564 | 1.74 | 80 | Curative (C) | 2018-08-03 | 2018-08-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101674639 |
| 20191241 | 20123565 | 1.81 | 77 | Neo-adjuvant (N) | 2022-01-10 | 2022-01-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101773306 |
| 20191244 | 20123566 | 1.89 | 84 | Adjuvant (A) | 2021-02-20 | 2021-02-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100078929 |
| 20191245 | 20123567 | 1.81 | 72.5 | Palliative (P) | 2017-06-17 | 2017-06-25 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100294713 |
| 20191247 | 20123568 | 1.52 | 58 | null | 2018-06-06 | 2018-06-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100551828 |
| 20191249 | 20123569 | 1.5 | 71.5 | Neo-adjuvant (N) | 2018-05-01 | 2018-05-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101498602 |